Infectious Diseases News and Research

RSS

Research shows intestinal parasite infestations reduce COVID-19 severity

Now, new research out of Mekelle, Ethiopia, examines the role of parasitic infestation on the prognosis of COVID-19. The research paper, which appears on the preprint server medRxiv, shows that intestinal parasitosis is protective against severe COVID-19.

4 Feb 2021

Study: Only 14% of the Bernese population developed antibodies against SARS-CoV-2

In the canton of Bern, only 14% of the adult population were infected with the coronavirus and developed antibodies against SARS-CoV-2.

4 Feb 2021

Emory MVA COVID-19 vaccine proven safe and effective in mice and monkeys

Researchers at Yerkes National Primate Research Center, Emory University, have developed a COVID-19 vaccine that has proven safe and effective in mice and monkeys.

4 Feb 2021

Phase I/II trial findings support use of CoronaVac vaccine in older individuals

Researchers in China have reported phase I/II clinical trial findings showing that the vaccine candidate CoronaVac is well tolerated among older individuals and effectively generates antibody responses against severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).

4 Feb 2021

Alzheimer's risk gene can increase COVID-19 susceptibility and severity

A City of Hope-led research team found that the same gene that increases the risk for Alzheimer's disease, ApoE4, can increase the susceptibility to and severity of COVID-19.

4 Feb 2021

Poll data shows disparities in older adults’ ability to isolate COVID-19 persons in homes

One of the most important ways to stop the spread of COVID-19 is for people who have tested positive or have symptoms, to isolate themselves from the other people they live with.

4 Feb 2021

Novel quantum sensor offers a new route to early diagnosis, preventive treatment

Oxygen is essential for human life, but within the body, certain biological environmental conditions can transform oxygen into aggressively reactive molecules called reactive oxygen species (ROS), which can damage DNA, RNA, and proteins.

4 Feb 2021

New drug cocktail offers hope to patients with highly drug-resistant tuberculosis

A new three-drug, all-oral, six-month treatment is providing hope to patients in Tajikistan with highly drug-resistant forms of tuberculosis, which until now had limited treatment options and poor prognosis.

3 Feb 2021

Clinical trials of new treatments for COVID-19 often do not include vulnerable populations

Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine researchers.

3 Feb 2021

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.

3 Feb 2021

Viral load the main driver of SARS-CoV-2 transmission

A study conducted by researchers in the UK and Spain suggests that viral load is the main determinant of transmission risk in cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

3 Feb 2021

Scientists receive award to explore how diet and metabolism influence the immune system

A pair of scientists from Van Andel Institute and the National Institute of Allergy and Infectious Diseases have been granted a three-year, $1.5 million Allen Distinguished Investigator award from The Paul G. Allen Frontiers Group, a division of the Allen Institute, to better understand how diet and metabolism influence the immune system's ability to fight off threats such as infections.

3 Feb 2021

100 million covid shots in 100 days doesn’t get us back to normal

April 30 will mark the end of the first 100 days of President Joe Biden's tenure. That's a benchmark presidents often set for making good on high-priority campaign promises.

3 Feb 2021

Genomic study suggests SARS-CoV-2 clade 20C was imported into Japan from the US

A new study describes the outcome of such sequencing efforts in Japan as an important tool towards containing the spread of the infection.

3 Feb 2021

Researchers report trial results of rectal microbicides at HIV R4P Virtual Conference

Researchers seeking to develop on-demand and behaviorally congruent HIV prevention options for people who practice anal sex are reporting the results of three early phase clinical trials of rectal microbicides at this week's HIV Research for Prevention (HIV R4P) Virtual Conference.

3 Feb 2021

New WHO essential diagnostics list expands the suite of tests to promote better health

To address the lack of access to tests and testing services in multiple countries, WHO since 2018 has published a yearly essential diagnostics list (EDL), a basket of recommended in vitro diagnostics that should be available at point-of-care and in laboratories in all countries to increase timely and life-saving diagnoses.

1 Feb 2021

Early induction of functional SARS-CoV-2-specific T cells linked with mild symptoms in COVID-19 patients

Humoral and cellular adaptive immunity are two immune mechanisms that act against pathogens. Humoral immunity is mediated by antibodies, while cellular immunity does not involve antibodies and is, instead, facilitated by T cells.

1 Feb 2021

Researchers explore rapid outbreak of COVID-19 in U.S. detention facility

To assess the transmission of SARS-CoV-2 in a detention facility experiencing a COVID-19 outbreak, researchers at the U.S. Centers for Disease Control and Prevention (CDC) conducted testing for detained individuals in six quarantined dormitories at various time points.

1 Feb 2021

Researchers in Japan compare two seroprevalence antibody tests for SARS-CoV-2

Researchers have shown that using reliable antibody tests in conjunction is an effective way to estimate seroprevalence in low prevalence settings.

1 Feb 2021

CDC examines COVID-19 outbreak among U.S. office workers: a case study in transmission

Researchers from the Centers for Disease Control and Prevention and the Federal Emergency Management Agency in the U.S. found that despite mitigation efforts, two COVID-19 outbreaks emerged among office workers in Washington, DC.

1 Feb 2021

Infectious Diseases News and Research

Research shows intestinal parasite infestations reduce COVID-19 severity

Study: Only 14% of the Bernese population developed antibodies against SARS-CoV-2

Emory MVA COVID-19 vaccine proven safe and effective in mice and monkeys

Phase I/II trial findings support use of CoronaVac vaccine in older individuals

Alzheimer's risk gene can increase COVID-19 susceptibility and severity

Poll data shows disparities in older adults’ ability to isolate COVID-19 persons in homes

Novel quantum sensor offers a new route to early diagnosis, preventive treatment

New drug cocktail offers hope to patients with highly drug-resistant tuberculosis

Clinical trials of new treatments for COVID-19 often do not include vulnerable populations

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

Viral load the main driver of SARS-CoV-2 transmission

Scientists receive award to explore how diet and metabolism influence the immune system

100 million covid shots in 100 days doesn’t get us back to normal

Genomic study suggests SARS-CoV-2 clade 20C was imported into Japan from the US

Researchers report trial results of rectal microbicides at HIV R4P Virtual Conference

New WHO essential diagnostics list expands the suite of tests to promote better health

Early induction of functional SARS-CoV-2-specific T cells linked with mild symptoms in COVID-19 patients

Researchers explore rapid outbreak of COVID-19 in U.S. detention facility

Researchers in Japan compare two seroprevalence antibody tests for SARS-CoV-2

CDC examines COVID-19 outbreak among U.S. office workers: a case study in transmission

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News